denosumab Articles
Denosumab reduces burden of giant-cell tumor of the bone
25 September 2012
Denosumab superior to zoledronic acid for breast cancer patients with bone metastases
15 August 2012
Daiichi Sankyo debuts bone cancer drug Ranmark in Japan
17 April 2012
Daiichi Sankyo files denosumab in Japan for osteoporosis
26 March 2012
Japanese approval for Regnite and Ranmark
18 January 2012
Backing for Japanese approval of Regnite, Ranmark and Cancidas
5 December 2011
US FDA approves expanded use of Amgen’s bone drug denosumab, which could boost potential sales to $2.4 billion
19 November 2010
Strong cancer drug results presented by Roche, Sanofi-Aventis, Merck KGaA, Amgen and Eisai at ESMO Congress
12 October 2010
Showing 1-13 of 13 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
